This article originally appeared on The DIV-Net October 25, 2010.
Linked here is a detailed quantitative analysis of Colgate-Palmolive Co. (CL). Below are some highlights from the above linked analysis:
Company Description: Colgate-Palmolive Company (Colgate) is a major consumer products company that markets oral, personal and household care, and pet nutrition products in more than 200 countries and territories.
Fair Value: I consider four calculations of fair value, see page 2 of the linked PDF for a detailed description:
1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number
CL is trading at a discount to 1.) and 3.) above. The stock is trading at a 16.1% discount to its calculated fair value of $91.57. CL earned a Star in this section since it is trading at a fair value.
Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:
1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%
CL earned two Stars in this section for 1.) and 3.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. CL earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1895 and has increased its dividend payments for 47 consecutive years.
Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA)? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:
1. NPV MMA Diff.
2. Years to > MMA
CL earned a Star in this section for its NPV MMA Diff. of the $2,603. This amount is in excess of the $500 target I look for in a stock that has increased dividends as long as CL has. If CL grows its dividend at 12.5% per year, it will take 3 years to equal a MMA yielding an estimated 20-year average rate of 3.4%. CL earned a check for the Key Metric ‘Years to >MMA’ since its 3 years is less than the 5 year target.
Memberships and Peers: CL is a member of the S&P 500 and a member of the Broad Dividend Achievers™ Index. The company’s peer group includes: Procter & Gamble Co. (PG) with a 3.0% yield, Kimberly-Clark Corporation (KMB) with a 4.0% yield, and Clorox Corporation (CLX) with a 3.2% yield.
Conclusion: CL earned one Star in the Fair Value section, earned two Stars in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of four Stars. This quantitatively ranks CL as a 4 Star-Buy.
Using my D4L-PreScreen.xls model, I determined the share price would need to increase to $139.09 before CL’s NPV MMA Differential decreased to the $500 minimum that I look for in a stock with 47 years of consecutive dividend increases. At that price the stock would yield 1.46%.
Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $500 NPV MMA Differential, the calculated rate is 6.9%. This dividend growth rate is below the 12.5% used in this analysis, thus providing a margin of safety. CL has a risk rating of 1.50 which classifies it as a low risk stock.
Demand for household and personal care products is generally stable and not affected by changes in the economy. Within personal care products, CL has focused the oral care category and has a worldwide toothpaste market share of approximately 45%. The company is also adept in utilizing sophisticated promotional tools. Near-term the CL changes in the Venezuelan bolivar could negatively affect results, but long-term the company should see above-industry-average growth with more resources being allocated to faster-growing markets. I plan to add to my position while the stock is trading below my fair value price of $91.57 and as my allocation allows. For additional information, including the stock’s dividend history, please refer to its data page.
Disclaimer: Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.
Full Disclosure: At the time of this writing, I was long in CL (1.9% of my Income Portfolio). See a list of all my income holdings here.
– Leggett & Platt, Inc. (LEG) Dividend Stock Analysis
– The Clorox Company (CLX) Dividend Stock Analysis
– HCC Insurance Holdings Inc. (HCC) Dividend Stock Analysis
– Universal Health Realty Income Trust (UHT) Dividend Stock Analysis
– More Stock Analysis